{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:28:31Z","timestamp":1762622911222},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S12","license":[{"start":{"date-parts":[[1987,12,1]],"date-time":"1987-12-01T00:00:00Z","timestamp":565315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1987,12]]},"DOI":"10.1007\/bf01312467","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T19:15:13Z","timestamp":1111778113000},"page":"S67-S70","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis"],"prefix":"10.1007","volume":"32","author":[{"given":"M.","family":"Campieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gionchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brignola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Migaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Tabanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bazzocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Miglioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"034","volume":"1","author":"JH Baron","year":"1962","unstructured":"Baron JH, Connell Am, Lennard-Jones JF: Sulphasalazine and salicylazosulphamidine in ulcerative colitis. Lancet 1:034?1036, 1962","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.5.5.437","volume":"5","author":"AP Dick","year":"1964","unstructured":"Dick AP, Grayson MJ, Carpenter RG, Petrie A: Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 5:437?442, 1964","journal-title":"Gut"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(65)90972-4","volume":"1","author":"JJ Misiewicz","year":"1965","unstructured":"Misiewicz JJ, Lennard-Jones JE, Connell AM, Baron JH, Avery Jones F: Controlled trial of sulphasalazine in maintenance therapy of ulcerative colitis. Lancet 1:185?188, 1965","journal-title":"Lancet"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.14.12.923","volume":"14","author":"AS Dissanayake","year":"1973","unstructured":"Dissanayake AS, Truelove SC: A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 14:923?924, 1973","journal-title":"Gut"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0016-5085(73)80035-6","volume":"64","author":"MA Peppercorn","year":"1973","unstructured":"Peppercorn MA, Goldman P: Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 64:240?245, 1973","journal-title":"Gastroenterology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cpt1972134539","volume":"13","author":"H Schroder","year":"1972","unstructured":"Schroder H, Campbell DES: Absorption, metabolism and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 13:539?551, 1972","journal-title":"Clin Pharmacol Ther"},{"key":"CR7","first-page":"832","volume":"16","author":"AK Azad Khan","year":"1975","unstructured":"Azad Khan AK, Johnston H, Truelove SC: Bacterial breakdown of sulphasalazine (Salazopyrin). Gut 16:832, 1975 (abstract)","journal-title":"Gut"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(77)90831-5","volume":"2","author":"AK Azad Khan","year":"1977","unstructured":"Azad Khan AK, Piris J, Truelove SC: An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2:892?895, 1977","journal-title":"Lancet"},{"key":"CR9","first-page":"632","volume":"21","author":"PAM Hees Van","year":"1980","unstructured":"Van Hees PAM, Bakker JH, Van Tongern JHM: Effect of sulphapiridine 5-aminosalicylic acid and placebo in patients with idiopathic proctitis: A study to determine the active therapeutic moiety of sulphasalazine. But 21:632?635, 1980","journal-title":"But"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198012253032602","volume":"303","author":"U Klotz","year":"1980","unstructured":"Klotz U, Maier K, Fischer C, Heikel K: Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N Engl J Med 303:1499?1502, 1980","journal-title":"N Engl J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.2.5321.1708","volume":"2","author":"SC Truelove","year":"1962","unstructured":"Truelove SC, Watkinson G: Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. Br Med J 2:1708?1711, 1962","journal-title":"Br Med J"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.21.3.232","volume":"21","author":"AK Azad Khan","year":"1980","unstructured":"Azad Khan AK, Howes DT, Piris J, Truelove SC: Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 21:232?240, 1980","journal-title":"Gut"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM197309062891001","volume":"289","author":"KM Das","year":"1973","unstructured":"Das KM, Eastwood MA, McManus IRA, Sircus W: Adverse reactions during salicylazo-sulphapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 289:491?495, 1973","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","volume":"1","author":"SC Truelove","year":"1956","unstructured":"Truelove SC, Richards WCD: Biopsy studies in ulcerative colitis. Br Med J 1:1315?1327, 1956","journal-title":"Br Med J"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(81)90523-7","volume":"2","author":"M Campieri","year":"1981","unstructured":"Campieri M, Lanfranchi GA, Bazzocchi G, et al: Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 2:270?271, 1981","journal-title":"Lancet"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF02555391","volume":"29","author":"M Campieri","year":"1986","unstructured":"Campieri M, Lanfranchi GA, Bazzocchi G, et al: Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis. Dis Colon Rectum 29:108?110, 1986","journal-title":"Dis Colon Rectum"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0016-5085(85)90485-8","volume":"89","author":"M Campieri","year":"1985","unstructured":"Campieri M, Lanfranchi GA, Brignola C, et al: 5-Aminosalicylic acid for treatment of inflammatory bowel disease. Gastroenterology 89:701?703, 1985 (letter)","journal-title":"Gastroenterology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gut.26.4.400","volume":"26","author":"M Campieri","year":"1985","unstructured":"Campieri M, Lanfranchi GA, Boschi S, et al: Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut 26:400?405, 1985","journal-title":"Gut"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(84)90462-8","volume":"1","author":"M Campieri","year":"1984","unstructured":"Campieri M, Lanfranchi GA, Brignola C, et al: 5-Aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine. Lancet 1:403, 1984 (letter)","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000199034","volume":"29","author":"M Campieri","year":"1984","unstructured":"Campieri M, Lanfranchi GA, Bertoni F, et al: A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion 29:204?208, 1984","journal-title":"Digestion"},{"key":"CR21","first-page":"1230","volume":"86","author":"JE Sandgren","year":"1984","unstructured":"Sandgren JE, McPhee MS, Greenberger NJ: Refractory distal ulcerative colitis: Response to therapy with 5-aminosalicylic acid (5-ASA) enemas. Gastroenterology 86: 1230, 1984 (abstract)","journal-title":"Gastroenterology"},{"key":"CR22","first-page":"15","volume":"18","author":"CP Willoughby","year":"1986","unstructured":"Willoughby CP, Campieri M, Lanfranchi GA, Truelove SC, Jewell DP: 5-Aminosalicylic acid (Pentasa) in enema form for the treatment of active ulcerative colitis. Ital J Gastroenterol 18:15?17, 1986","journal-title":"Ital J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01312467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01312467\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01312467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T14:12:04Z","timestamp":1586182324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01312467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,12]]},"references-count":22,"journal-issue":{"issue":"S12","published-print":{"date-parts":[[1987,12]]}},"alternative-id":["BF01312467"],"URL":"https:\/\/doi.org\/10.1007\/bf01312467","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,12]]}}}